Høgdall EV - Search Results

1

Changes in plasma tetranectin following hip surgery with or without thrombotic complications.

Høgdall CK, Høgdall EV, Jørgensen LN, Clemmensen I. Høgdall CK, et al. Among authors: hogdall ev. Thromb Res. 1992 Aug 15;67(4):399-405. doi: 10.1016/0049-3848(92)90269-g. Thromb Res. 1992. PMID: 1412218

2

CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters.

Høgdall CK, Høgdall EV, Arends J, Nørgaard-Pedersen B, Smidt-Jensen S, Larsen SO. Høgdall CK, et al. Among authors: hogdall ev. Prenat Diagn. 1992 Mar;12(3):223-7. doi: 10.1002/pd.1970120312. Prenat Diagn. 1992. PMID: 1375379

3

Plasma tetranectin and ovarian neoplasms.

Høgdall CK, Høgdall EV, Hørding U, Daugaard S, Clemmensen I, Nørgaard-Pedersen B, Toftager-Larsen K. Høgdall CK, et al. Among authors: hogdall ev. Gynecol Oncol. 1991 Nov;43(2):103-7. doi: 10.1016/0090-8258(91)90053-8. Gynecol Oncol. 1991. PMID: 1743549

4

Tetranectin in amniotic fluid, maternal serum and fetal fluids.

Høgdall EV, Høgdall CK, Clemmensen I, Nørgaard-Pedersen B, Loft AG. Høgdall EV, et al. Among authors: hogdall ck. Scand J Clin Lab Invest. 1991 Sep;51(5):411-5. doi: 10.3109/00365519109091634. Scand J Clin Lab Invest. 1991. PMID: 1947725

5

[15(S)-15-methyl-prostaglandin F2 alpha. A potent synthetic prostaglandin F2 alpha for treatment of postpartum atony].

Høgdall EV, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Ugeskr Laeger. 1991 Nov 11;153(46):3260-2. Ugeskr Laeger. 1991. PMID: 1957386 Danish. No abstract available.

6

[Treatment of severe postpartum atony with prostaglandin].

Høgdall CK, Høgdall E. Høgdall CK, et al. Ugeskr Laeger. 1989 Sep 18;151(38):2410-3. Ugeskr Laeger. 1989. PMID: 2678650 Review. Danish.

7

Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients.

Høgdall CK, Høgdall EV, Hørding U, Clemmensen I, Nørgaard-Pedersen B, Toftager-Larsen K. Høgdall CK, et al. Among authors: hogdall ev. Scand J Clin Lab Invest. 1993 Nov;53(7):741-6. doi: 10.3109/00365519309092579. Scand J Clin Lab Invest. 1993. PMID: 8272761

8

Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancer.

Høgdall CK, Høgdall EV, Hørding U, Toftager-Larsen K, Arends J, Nørgaard-Pedersen B, Clemmensen I. Høgdall CK, et al. Among authors: hogdall ev. Acta Oncol. 1996;35(1):63-9. doi: 10.3109/02841869609098481. Acta Oncol. 1996. PMID: 8619942

9

OVX1 radioimmunoassay results are dependent on the method of sample collection and storage.

Hogdall EV, Hogdall CK, Kjaer SK, Xu F, Yu Y, Bast RC, Blaakaer J, Jacobs IJ. Hogdall EV, et al. Among authors: hogdall ck. Clin Chem. 1999 May;45(5):692-4. Clin Chem. 1999. PMID: 10222361 No abstract available.

10

Alpha-fetoprotein in human fetal cerebrospinal fluid.

Christiansen M, Høgdall CK, Høgdall EV. Christiansen M, et al. Among authors: hogdall ev, hogdall ck. Clin Chim Acta. 2000 Jan 20;291(1):35-41. doi: 10.1016/s0009-8981(99)00195-3. Clin Chim Acta. 2000. PMID: 10612715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters